Form 4 for MMM 3M
Accepted 2024-11-04 00:00:00 ET · period of report 2024-11-01 · accession 0001127602-24-026337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-04 | 2024-11-01 | MMM | Reinseth Theresa E | CAO, Sr VP | M - OptEx | $127.22 | +1,899 | 6,287 | +43% | +$241.6K |
| D | 2024-11-04 | 2024-11-01 | MMM | Reinseth Theresa E | CAO, Sr VP | F - Tax | $127.22 | -866 | 5,421 | -14% | -$110.2K |
| D | 2024-11-04 | 2024-11-01 | MMM | Reinseth Theresa E | CAO, Sr VP | M - OptEx | $0.00 | -1,899 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | M | A | 1,899 | $127.22 | 6,287.05 | D | — | — | (F1) The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |
| 2 | Common | Common Stock | 2024-11-01 | F | D | 866 | $127.22 | 5,421.05 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-11-01 | M | D | 1,899 | $0.00 | 0 | D | — · — to — | 1,899 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of 3M common stock. (F3) The restricted stock units vest in three years from the grant date. |